Skip to content

Efficacy on Helicobacter Pylori Eradication With Two Antibiotic Regimens

Efficacy on Helicobacter Pylori Eradication With Sequential Antibiotic Compared to Triple Therapy for 14 Days

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02395458
Enrollment
142
Registered
2015-03-23
Start date
2013-03-31
Completion date
2015-02-28
Last updated
2015-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Infections

Keywords

Sequential therapy, Triple therapy, Eradication

Brief summary

Clinical trial to compare efficacy on eradicating Helicobacter pylori with two antibiotic strategies: sequential with amoxicillin and omeprazole 5 days and clarithromycin with metronidazole and omeprazole 5 days or omeprazole with clarithromycin and amoxicillin 14 days.

Detailed description

In patients with documented infection with Helicobacter pylori after endoscopy and biopsy, two modalities of treatment were compared, and after a control endoscopy and biopsy, eradication was assessed as well as side effects of both treatments.

Interventions

Patient receive Omeprazole plus amoxicillin during 5 days and then omeprazole plus clarithromycin and metronidazole during another 5 days

Patient receive Omeprazole plus amoxicillin and Clarithromycin during 14 days

Sponsors

Coordinación de Investigación en Salud, Mexico
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Helicobacter pylori infection in biopsy * Eradication required

Exclusion criteria

* Antibiotic received two weeks prior * Previous treatment for H pylori infection * Allergy to any of the treatment drugs * Smoking \> 5 cigarettes daily.

Design outcomes

Primary

MeasureTime frameDescription
Eradication6 to 8 week after treatmentHelicobacter pylori in gastric biopsy

Secondary

MeasureTime frameDescription
Side effectstwo weeks after beginning of treatmentNausea, vomiting, stomach ache

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026